Cargando…

Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers

Detalles Bibliográficos
Autores principales:	Fusco, Nicola, Malapelle, Umberto, Criscitiello, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845888/ https://www.ncbi.nlm.nih.gov/pubmed/36660432 http://dx.doi.org/10.3389/fmolb.2022.1117323

Ejemplares similares

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
por: Venetis, Konstantinos, et al.
Publicado: (2022)

Editorial: Cancer diagnostics in solid tumors-from pathology to precision oncology
por: Malapelle, Umberto, et al.
Publicado: (2023)

Editorial: Insights in molecular diagnostics and therapeutics: 2022
por: Becatti, Matteo, et al.
Publicado: (2023)

Editorial: The “proteine 2022” conference
por: Balestri, Francesco, et al.
Publicado: (2023)

Editorial: Methods in Metabolomics 2022
por: Buescher, Joerg, et al.
Publicado: (2023)

Editorial: Reviews in ubiquitin signaling: 2022
por: Fletcher, Adam J., et al.
Publicado: (2023)

Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials
por: Invernizzi, Marco, et al.
Publicado: (2022)

Editorial: The genome’s rising star: Transfer RNA-derived small fragments
por: Yan, Wei
Publicado: (2022)

Editorial: Insights in protein biochemistry: protein biophysics 2022
por: Labrou, Nikolaos E., et al.
Publicado: (2023)

Editorial: Application of Systems Biology in Molecular Characterization and Diagnosis of Cancer
por: Zhang, Cheng, et al.
Publicado: (2021)

Editorial: Novel approaches to study metals in molecular biology
por: Padilla-Benavides, Teresita, et al.
Publicado: (2023)

Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial intelligence
por: Khan, Abbas, et al.
Publicado: (2022)

Editorial: Application of systems biology in molecular characterization and diagnosis of cancer, Volume II
por: Wei, Yongjun, et al.
Publicado: (2022)

Editorial: Gynecological and gastrointestinal cancers: Recent advances in molecular diagnosis and targeted therapy
por: Zhang, Lan, et al.
Publicado: (2023)

Editorial: Novel Molecular Mechanisms and Innovative Therapeutic Approaches for Age-Associated Diseases
por: Sun, Leming, et al.
Publicado: (2022)

Editorial: Molecular Aspects of Mucopolysaccharidoses
por: Węgrzyn, Grzegorz, et al.
Publicado: (2022)

Editorial: Exosomal biomarkers: Roles in diagnostics and therapeutics
por: Gupta, Dwijendra K.
Publicado: (2023)

Editorial: Novel advances in gastrointestinal cancer treatment
por: Liu, Yanqing, et al.
Publicado: (2023)

Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis and Phenotyping of Carotid Artery Stenosis
por: Wang, Wei, et al.
Publicado: (2021)

Editorial: Weak Interactions in Molecular Machinery
por: Isaacson, Rivka L., et al.
Publicado: (2019)

Editorial: Molecular chaperones and human disease
por: Chakafana, Graham, et al.
Publicado: (2022)

Editorial: Methods and applications in molecular diagnostics
por: Arora, Naina, et al.
Publicado: (2023)

Editorial: Oxidative stress in degenerative bone and joint diseases: novel molecular mechanisms and therapeutic potential
por: Lin, Jialiang, et al.
Publicado: (2023)

Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment
por: Kashani, Narjes Riahi, et al.
Publicado: (2022)

Editorial: The HSP70 Molecular Chaperone Machines
por: Goloubinoff, Pierre
Publicado: (2017)

Editorial: Molecular Diagnostics in the Detection of Neurodegenerative Disorders
por: Agrawal, Megha, et al.
Publicado: (2017)

Editorial: Insights in molecular diagnostics and therapeutics: 2021
por: Becatti, Matteo, et al.
Publicado: (2022)

Editorial: Leveraging machine learning for omics-driven biomarker discovery
por: Li, Sheng, et al.
Publicado: (2023)

Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications
por: Afzal, Samia, et al.
Publicado: (2022)

Editorial: New Strategies for the Diagnosis and Treatment of Multi-Drug Resistant Bacteria or Fungi in Wounds
por: Chin, Kok-Yong
Publicado: (2023)

Editorial: Advances in Molecular Docking and Structure-Based Modelling
por: Rebehmed, Joseph, et al.
Publicado: (2022)

Editorial: Intracellular Molecular Processes Affected by pH
por: Antosiewicz, Jan M., et al.
Publicado: (2022)

Editorial: Molecular Dynamics and Machine Learning in Drug Discovery
por: Decherchi, Sergio, et al.
Publicado: (2021)

Editorial: Machine Learning Methodologies to Study Molecular Interactions
por: Yakimovich, Artur, et al.
Publicado: (2021)

Editorial: Molecular determinants of protein assemblies in health and disease
por: Kroschwald, Sonja, et al.
Publicado: (2022)

Editorial: Weak interactions in molecular machinery volume II
por: Corrales-Guerrero, Laura, et al.
Publicado: (2023)

Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma
por: Kumar, Vinay, et al.
Publicado: (2023)

The Rise of the Nested Multicompartment Model in Synthetic Cell Research
por: Altamura, Emiliano, et al.
Publicado: (2021)

Editorial: Mechanisms of Novel Drugs and Gene Modifiers in the Treatment of Cystic Fibrosis
por: Veit, Guido, et al.
Publicado: (2022)

Editorial: Molecular Insights Into Ligand-Receptor Interactions on the Cell Surface
por: Marchetti, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_it4gp4hnabod93di2069c9u6l9